22nd Century Group, Inc.

22nd Century Group Files 2019 Annual Report

Maintains strong balance sheet; momentum continues for Modified Risk Tobacco Product and major milestone achieved in hemp/cannabis research

News Release – March 12, 2020

View Press Release

22nd Century Announces Exclusive Worldwide Agreement with KeyGene for Genetic Development of Hemp/Cannabis

Strategic collaboration will bolster 22nd Century’s position as a global leader in hemp/cannabis genetics

News Release – April 09, 2019

View Press Release

22nd Century Group to Present its Modified Risk Tobacco Product Application to FDA’s Tobacco Products Scientific Advisory Committee

Meeting is next official step toward possible marketing authorization for 22nd Century Group’s VLN® product in the United States

News Release – December 23, 2019

View Press Release

CDC Survey Finds Most U.S. Adults, including 80% of Smokers, Favor Lowering Nicotine Levels in Cigarettes to Make Them Less Addictive

Studies show that FDA enjoys broad consumer support to dramatically lower nicotine in cigarettes

News Release – July 12, 2019

View Press Release

22nd Century Group Enters CBD Health and Wellness Market with Investment in Panacea Life Sciences, Inc.

Investment provides platform to commercialize 22nd Century’s unique hemp/cannabis plant lines in development and leverage strengths in consumer-packaged-goods and FDA-regulatory affairs

News Release – December 03, 2019

View Press Release

Company Mission & Profile

22nd Century Group is a plant biotechnology company focused on reducing nicotine in tobacco and creating new hemp/cannabis plants

About Us

Email Alerts

Stay informed and receive company updates straight to your inbox.

Sign up today

Latest News

22nd Century Group, Inc. Files 2019 Annual Report

View Press Release View All

22nd Century Announces Important New Achievements with KeyGene
View Press Release

22nd Century Group Adds to Leadership Team
View Press Release

Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use of Very Low Nicotine Content Cigarettes Does Not Lead to Compensatory Smoking
View Press Release

Latest Media

View All Media

February 14, 2020

Reduced-Nicotine Smokes May Be Arriving to the U.S. Shortly
View Media Release

November 8, 2019

Webcast: Third Quarter Business Update
View Media Release

July 31, 2018

The urgent case for nonaddictive cigarettes
View Media Release